ESC 365 - Optimizing the treatment of pulmonary embolism

ESC Premium Access

Optimizing the treatment of pulmonary embolism

Event: ESC CONGRESS 2016

Topic: Acute pulmonary embolism

Session type: Advances in Science

Date: 28 August 2016

Time: 16:30 - 18:00

Congress Session

5 presentations in this session

State of the art in the management of pulmonary embolism.

Speaker: Doctor C. Becattini (Perugia, IT)

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation

Speaker: Doctor E. Klok (Leiden, NL)

National trends in inferior vena cava filter placement in the United States from 2005 to 2013

Speaker: Professor D. Brown (St Louis, US)

Is rivaroxaban associated with shorter hospital stays and reduced costs vs. parenteral bridging to warfarin among pulmonary embolism patients?

Speaker: Doctor E. Weeda (Storrs, US)

Future direction for research in pulmonary embolism.

Speaker: Professor H. Buller (Amsterdam, NL)

5 speakers from this session

Doctor Cecilia Becattini

University of Perugia, Perugia (Italy)

11 presentations

0 follower

Doctor Erik Klok

Leiden University Medical Centre, Leiden (Netherlands (The))

3 presentations

0 follower

Professor David Lloyd Brown

Washington University School of Medicine, St Louis (United States of America)

1 presentation

0 follower

Doctor Erin Weeda

University of Connecticut, Storrs (United States of America)

0 follower

Professor Harry Buller

AMC Medical Research BV, Amsterdam (Netherlands (The))

3 presentations

0 follower

This platform is supported by